Co-Diagnostics, Inc.
CODX
$0.375
$0.01985.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.84% | -62.09% | 14.79% | -61.80% | 33.00% |
| Total Depreciation and Amortization | 14.13% | 18.53% | 10.85% | 4.62% | 4.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.52% | 266.23% | 911.61% | 159.71% | -53.10% |
| Change in Net Operating Assets | 48.48% | 174.89% | -89.20% | -142.68% | 426.28% |
| Cash from Operations | -72.25% | -25.40% | 7.41% | -43.48% | -19.17% |
| Capital Expenditure | 84.29% | 26.29% | 79.64% | -123.62% | -58.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.64% | 68.51% | -127.86% | 270.16% | 119.01% |
| Cash from Investing | -97.23% | 78.09% | -129.57% | 263.22% | 118.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 86.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 165.06% | -- | -- | -- | 86.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -268.08% | 14.75% | -223.68% | 149.25% | 107.99% |